CPIX
CUMBERLAND PHARMACEUTICALS INC
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$6.70
−6.69%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.38x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.76x
- Price / sales
- 3.21x
- Price / cash flow
- 134.57x
Enterprise value
- Enterprise value
- $100.9M
- EV / sales
- 3.23x
- EV / EBITDA
- -19.88x
- EV / EBIT
- -10.48x
- Market cap
- $100.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026